While the role of LOXL1 and LOXL3 in cancer still remains mostly unknown, LOXL4 promotes cell migration and invasion via the FAK (Focal adhesion kinase 1)/Src (Proto-oncogene tyrosin-protein kinase Src) pathway [104]. This evidence concerns the gene SRC and cancer.